We are monitoring the impact of COVID-19 on Asia Pacific Acne Medication Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 6563
Share on
Share on

APAC Acne Medication Market Research Report – Segmented By Type, Route Of Administration, Drug Class and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends and Forecast (2021 to 2026)

Pulished: April, 2021
ID: 6563
Pages: 145

APAC Acne Medication Market Size (2021 to 2026)

The size of the Asia Pacific Acne Medication Market is projected to grow at a high CAGR from 2021 to 2026.

Lack of sleep, high intake of smoking and alcohol consumption, misusage of drugs, emotional and work-related stress are significant factors driving the acne medication market in the APAC region. Acne vulgaris affects nearly 85% of people age 12-25 years, according to the Global Burden of Disease Study. Increasing demand for minimally invasive cosmetic treatment procedures is mounting remarkably. Escalating demand for brisk treatments and swift results are projected to drive the need for equipment-based procedures like laser treatments. Rising awareness of acne issues among the single and consciousness regarding the present and upcoming treatments, advanced technologies, and augmenting per capita income motivating the customers in spending more on personal care are accelerating the acne treatment market in this region.

The usability of alternatives for acne drugs and therapies served by local players, lack of experienced and skilled dermatologists restrain the market. Rising demand for self-medication without a doctor’s prescription and the significance of substitute therapies for nursing acne has been obstructing the sales of branded acne products.

This research report on the Asia Pacific Acne Medication Market has been segmented & sub-segmented into the following categories:

  • By Type: OTC drugs and Prescription drugs
  • By Route of Administration: Topical and Oral
  • By Drug Class: Antibiotics, Anti-Inflammatory Drugs, Anti-Microbial, Combination Drugs, Hormonal Agents, Oral Retinoid and Topical Retinoid
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore, and Rest of APAC

Regional Analysis:

The Asia-Pacific market for acne medication is anticipated to have rapid growth in the market in terms of revenue because of common skin diseases and conditions like abnormal hormone growth, high intake of carbohydrates, and massive consumption of junk food, and excessive intake of fat creating foods.

The Indian acne medication market is anticipated to enlarge the market with a 9.2% CAGR during the analysis period. There are around 200-300 million acne sufferers, finally aiding the market growth in India. The market is attributed to the growing demand of the population in expending on facial.

China is expected to lead the market over the period. Increase in many product launches, growing demand for acne therapies, and uplift in healthcare expenses and awareness relevant to newly enhanced therapies that can substitute conventional acne treatment in this region. Rising behavior and unhealthy eating habits and increasing income bolstered market growth during the analysis period. Moreover, accessibility of experienced and knowledgeable dermatologists, involve the patients virtually in treatment designing are anticipated to add fuel to the acne treatment growth in terms of income. India and China are expected to have rapid growth in the region.

Some of the major companies dominating the Asia Pacific acne medication market by their products and services include Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co. Inc., Amgen, Inc., Abbott Laboratories, AstraZeneca, Eli Lilly and Company, Mylan N.V., and Daiichi Sankyo Company, Ltd.

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Type                                                              

                                5.1.1 Introduction                                           

                                5.1.2 OTC drugs                                

                                5.1.3 Prescription drugs                                

                                5.1.4  Y-o-Y Growth Analysis, By type                                     

                                5.1.5  Market Attractiveness Analysis, By type                                   

                                5.1.6 Market Share Analysis, By type                                      

                5.2 Route of administration                                                        

                                5.2.1 Introduction                                           

                                5.2.2 Topical                                      

                                5.2.3 Oral                                            

                                5.2.4 Y-o-Y Growth Analysis, By route of administration                                

                                5.2.5 Market Attractiveness Analysis, By route of administration                                              

                                5.2.6 Market Share Analysis, By route of administration                                

                5.3 Drug class                                                    

                                5.3.1 Introduction                                           

                                5.3.2 Antibiotics                                               

                                5.3.3 Anti-inflammatory drugs                                   

                                5.3.4 Anti-microbials                                      

                                5.3.5 Combination drugs                                              

                                5.3.6 Hormonal agents                                  

                                5.3.7 Oral retinoids                                         

                                5.3.8 Topical retinoids                                   

                                5.3.7 Y-o-Y Growth Analysis, By drug class                                            

                                5.3.8  Market Attractiveness Analysis, By drug class                                         

                                5.3.9  Market Share Analysis, By drug class                                          

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By type                 

                                                6.1.3.3 By route of administration                            

                                                6.1.3.4 By drug class                       

                                6.1.4  Market Attractiveness Analysis                                     

                                                6.1.4.1 By Geographical Area                     

                                                6.1.4.2 By type                 

                                                6.1.4.3 By route of administration                            

                                                6.1.4.4 By drug class                       

                                6.1.5  Market Share Analysis                                      

                                                6.1.5.1 By Geographical Area                     

                                                6.1.5.2 By type                 

                                                6.1.5.3 By route of administration                            

                                                6.1.5.4 By drug class                       

                6.2 China                                                             

                6.3 India                                                              

                6.4 Japan                                                            

                6.5 South Korea                                                               

                6.6 Australia                                                      

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1 Pfizer Inc.                                                    

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 GlaxoSmithKline plc                                                

                8.3 Novartis AG                                                

                8.4 Merck & Co. Inc                                                        

                8.5 Amgen, Inc.                                                

                8.6 Abbott Laboratories                                                               

                8.7 Eli Lilly and Company                                                              

                8.8 Daiichi Sankyo Company, Ltd                                                              

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10. Market Outlook and Investment Opportunities                                                                         

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of route, by Type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

  1. Asia Pacific Acne Medication Market, By Type, From 2021 to 2026 (USD Billion)
  2. Asia Pacific Otc drugs Market, By Region, From 2021 to 2026 (USD Billion)
  3. Asia Pacific Prescription drugs Market, By Region, From 2021 to 2026 (USD Billion)
  4. Asia Pacific Acne Medication Market, By Route of administration, From 2021 to 2026 (USD Billion)
  5. Asia Pacific Topical Market, By Region, From 2021 to 2026 (USD Billion)
  6. Asia Pacific Oral Market, By Region, From 2021 to 2026 (USD Billion)
  7. Asia Pacific Acne Medication Market, By Drug class, From 2021 to 2026 (USD Billion)
  8. Asia Pacific Antibiotics Market, By Region, From 2021 to 2026 (USD Billion)
  9. Asia Pacific Anti-inflammatory  Market, By Region, From 2021 to 2026 (USD Billion)
  10. Asia Pacific Antimicrobials Market, By Region, From 2021 to 2026 (USD Billion)
  11. Asia Pacific Combination Market, By Region, From 2021 to 2026 (USD Billion)
  12. Asia Pacific Hormonla agents Market, By Region, From 2021 to 2026 (USD Billion)
  13. Asia Pacific Oral retinoids Market, By Region, From 2021 to 2026 (USD Billion)
  14. Asia Pacific Topical retinoids Market, By Region, From 2021 to 2026 (USD Billion)
  15. Japan Acne Medication Market, By Type, From 2021 to 2026 (USD Billion)
  16. Japan Acne Medication Market, By Route of administration, From 2021 to 2026 (USD Billion)
  17. Japan Acne Medication Market, By Drug class, From 2021 to 2026 (USD Billion)
  18. China Acne Medication Market, By Type, From 2021 to 2026 (USD Billion)
  19. China Acne Medication Market, By Route of administration, From 2021 to 2026 (USD Billion)
  20. China Acne Medication Market, By Drug class, From 2021 to 2026 (USD Billion)
  21. India Acne Medication Market, By Type, From 2021 to 2026 (USD Billion)
  22. India Acne Medication Market, By Route of administration, From 2021 to 2026 (USD Billion)
  23. India Acne Medication Market, By Drug class, From 2021 to 2026 (USD Billion)
  24. Australia Acne Medication Market, By Type, From 2021 to 2026 (USD Billion)
  25. Australia Acne Medication Market, By Route of administration, From 2021 to 2026 (USD Billion)
  26. Australia Acne Medication Market, By Drug class, From 2021 to 2026 (USD Billion)
  27. South Korea Acne Medication Market, By Type, From 2021 to 2026 (USD Billion)
  28. South Korea Acne Medication Market, By Route of administration, From 2021 to 2026 (USD Billion)
  29. South Korea Acne Medication Market, By Drug class, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample